ReportsnReports.com adds report Global Drug-eluting Stent Market 2014-2018 to its store. Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries.
Complete report is available at http://www.reportsnreports.com/reports/274562-global-drug-eluting-stent-market-2014-2018.html.
Analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD.
The Global Drug-eluting Stent (DES) Market 2014-2018, has been prepared
based on an in-depth market analysis with inputs from industry experts.
The report covers the Americas, and the EMEA and APAC regions; it also
covers the Global Drug Eluting Stent market landscape and its growth
prospects in the coming years. The report also includes a discussion of
the key vendors operating in this market.
Further, the report states that the biggest challenge the market is facing
is the decline in the ASP of DESs. There has been a steady decline in the
prices of DESs worldwide because of the increased competition and the high
rate of adoption. The reduction in the ASP has a negative impact on the
overall market revenue.
The report recognizes the following companies as the key players in Global Drug-eluting Stent Market: Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp.
Other vendors mentioned in the report are B. Braun Melsungen AG, Biosensors International Ltd., BIOTRONIK SE & Co. KG, Cook Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corp., and Sorin Group USA Inc.
Purchase Report Directly @ http://www.reportsnreports.com/purchase.aspx?name=274562.
Key questions answered in this report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on firstname.lastname@example.org and we would be happy to help you find the business intelligence that you need. Not limited to the Medical Devices ReportsnReports.com offers research studies on agriculture, consumer goods, environment, advanced materials, public sector, food and beverages, energy and power, healthcare, automotive, manufacturing & construction, semiconductor and electronics, IT & telecommunication, pharmaceuticals, retail, water, banking and financial services , advanced materials and much more.